Pharmacist's Influence on Breast Cancer Patient Quality of Life (PIBC)

University Hospital "Sestre Milosrdnice"

Status: Completed

Conditions: Breast Cancer, Quality of Life

Treatments: Behavioral: Pharmacist's behavioral intervention

Study type: Interventional

Funder types: Other

Identifiers

NCT02746666

1705201504032016

Details and patient eligibility

About

The purpose of this study is to investigate the impact of pharmacist behavioral intervention's influence on breast cancer patients' quality of life. Croatian randomized controlled trial. Targeted population: general population of breast cancer patients under the first adjuvant anthracycline chemotherapy. Primary outcome: difference in EORTC QLQ-BR23 questionnaire result from the baseline to after 3 week cycle.

Enrollment: 70 patients

Sex: Female

Volunteers: No Healthy Volunteers

Inclusion criteria

• Early breast cancer
• First adjuvant chemotherapy
• Chemotherapy protocol: anthracycline x 4

Exclusion criteria

• Cardiovascular comorbidities
• Regular nausea or vomiting during six months before enrollment
• Unable to answer the quality of life questionnaire on their own

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

70 participants in 2 patient groups

Intervention

Experimental group

Description:

Under pharmacist's behavioral intervention

Treatment:

Behavioral: Pharmacist's behavioral intervention

Control

No Intervention group

Description:

No pharmacist's behavioral intervention